A Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to look at the effects of different anti-HIV drug combinations
on body fat changes in HIV-positive patients who have never received anti-HIV therapy before.
Phase:
Phase 4
Details
Lead Sponsor:
Glaxo Wellcome
Treatments:
Abacavir Lamivudine Lamivudine, zidovudine drug combination Nelfinavir Stavudine Zidovudine